South Street Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.7M Sell
27,934
-492
-2% -$499K 3.72% 10
2025
Q4
$30.5M Sell
28,426
-1,264
-4% -$1.21M 4.29% 6
2025
Q3
$22.7M Buy
29,690
+2,104
+8% +$1.57M 2.97% 11
2025
Q2
$21.5M Sell
27,586
-508
-2% -$395K 3.19% 13
2025
Q1
$23.2M Sell
28,094
-564
-2% -$469K 3.79% 4
2024
Q4
$22.1M Sell
28,658
-3,749
-12% -$3.1M 3.39% 10
2024
Q3
$28.7M Sell
32,407
-8,093
-20% -$7.28M 4.36% 4
2024
Q2
$36.7M Sell
40,500
-2,204
-5% -$1.76M 5.56% 2
2024
Q1
$33.2M Sell
42,704
-104
-0.2% -$74K 5.3% 3
2023
Q4
$25M Sell
42,808
-39
-0.1% -$22.8K 4.66% 4
2023
Q3
$23M Buy
42,847
+16
+0% +$8.24K 4.62% 3
2023
Q2
$20.1M Sell
42,831
-5,529
-11% -$2.32M 3.98% 5
2023
Q1
$16.6M Buy
48,360
+94
+0.2% +$31.7K 3.41% 9
2022
Q4
$17.7M Sell
48,266
-330
-0.7% -$117K 3.9% 4
2022
Q3
$15.7M Sell
48,596
-543
-1% -$172K 3.87% 4
2022
Q2
$15.9M Sell
49,139
-374
-0.8% -$112K 3.63% 7
2022
Q1
$14.2M Sell
49,513
-39,337
-44% -$10.1M 2.68% 18
2021
Q4
$24.5M Sell
88,850
-820
-0.9% -$208K 4.3% 3
2021
Q3
$20.7M Sell
89,670
-1,027
-1% -$253K 3.95% 6
2021
Q2
$20.8M Buy
+90,697
New +$18.2M 3.86% 5
2021
Q1
Sell
-99,116
Closed -$16.7M 48
2020
Q4
$16.7M Buy
99,116
+970
+1% +$145K 3.55% 13
2020
Q3
$14.5M Buy
98,146
+296
+0.3% +$45.8K 3.51% 13
2020
Q2
$16.1M Sell
97,850
-727
-0.7% -$112K 4.3% 8
2020
Q1
$13.7M Sell
98,577
-587
-0.6% -$80.7K 4.5% 6
2019
Q4
$13M Buy
99,164
+414
+0.4% +$48K 3.37% 17
2019
Q3
$11M Buy
98,750
+610
+0.6% +$67.9K 3.22% 17
2019
Q2
$10.9M Buy
98,140
+7,060
+8% +$831K 3.24% 18
2019
Q1
$11.8M Buy
91,080
+75,930
+501% +$9.23M 3.58% 13
2018
Q4
$1.75M Sell
15,150
-20
-0.1% -$2.23K 0.62% 30
2018
Q3
$1.63K Sell
15,170
-300
-2% -$30K 0.25% 35
2018
Q2
$1.32M Hold
15,470
0.4% 36
2018
Q1
$1.2K Buy
15,470
+50
+0.3% +$4.03K 0.12% 36
2017
Q4
$1.3M Sell
15,420
-2,070
-12% -$176K 0.39% 34
2017
Q3
$1.5K Hold
17,490
0.29% 35
2017
Q2
$1.44M Hold
17,490
0.47% 35
2017
Q1
$1.47K Sell
17,490
-50
-0.3% -$4K 0.2% 37
2016
Q4
$1.29M Sell
17,540
-10,190
-37% -$759K 0.45% 37
2016
Q3
$2.23M Hold
27,730
0.69% 31
2016
Q2
$2.18M Hold
27,730
0.69% 30
2016
Q1
$2M Buy
27,730
+1,050
+4% +$79.5K 0.66% 29
2015
Q4
$2.25M Hold
26,680
0.72% 30
2015
Q3
$2.23M Sell
26,680
-1,990
-7% -$168K 0.75% 30
2015
Q2
$2.39M Hold
28,670
0.75% 31
2015
Q1
$2.08K Hold
28,670
0.62% 34
2014
Q4
$1.98M Hold
28,670
0.65% 34
2014
Q3
$1.86M Hold
28,670
0.67% 36
2014
Q2
$1.78K Sell
28,670
-200
-0.7% -$11.9K 0.5% 36
2014
Q1
$1.7M Hold
28,870
0.68% 33
2013
Q4
$1.47M Buy
28,870
+1,400
+5% +$70.1K 0.62% 35
2013
Q3
$1.38M Buy
27,470
+200
+0.7% +$10.5K 0.66% 34
2013
Q2
$1.34M Buy
+27,270
New +$1.48M 0.7% 33

Other funds holding LLY

South Street Advisors's LLY Position: Q1 2026 in Review

South Street Advisors reduced its Eli Lilly (LLY) stake by 1.7% in Q1 2026, selling an estimated $499K and leaving 27,934 shares worth $25.7M. The position accounts for 3.72% of the portfolio, ranked #10.

South Street Advisors first reported a position in LLY in Q2 2013 and has held it in 51 quarters since. The position peaked at $36.7M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • South Street Advisors held 27,934 shares of Eli Lilly worth $25.7M as of Q1 2026.
  • South Street Advisors sold 492 Eli Lilly shares in Q1 2026, an estimated $499K.
  • Eli Lilly made up 3.72% of South Street Advisors's portfolio in Q1 2026, its #10 holding.
  • South Street Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 51 quarters since.
  • South Street Advisors's Eli Lilly position peaked at $36.7M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on South Street Advisors's 13F filing for Q1 2026, filed 13 May 2026.